Klein, Julian A. F.
Krüger, Lisa J.
Tobian, Frank
Gaeddert, Mary
Lainati, Federica
Schnitzler, Paul
Lindner, Andreas K.
Nikolai, Olga
Knorr, B.
Welker, A.
de Vos, Margaretha
Sacks, Jilian A.
Escadafal, Camille
Denkinger, Claudia M. http://orcid.org/0000-0002-7216-7067
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2
https://doi.org/10.1007/s15010-021-01681-y
Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test
https://doi.org/10.1007/s00430-021-00710-9
Funding for this research was provided by:
Unitaid (2019-32-FIND MDR)
World Health Organization
Universitätsklinikum Heidelberg
Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
Foundation of innovative new diagnostics
DFID (300341-102)
Universitätsklinikum Heidelberg
Article History
Received: 17 March 2021
Accepted: 5 May 2021
First Online: 24 May 2021
Declarations
:
: The methodology for this study was approved by the Human Research Ethics committee of the Medical Faculty, University of Heidelberg (Ethics approval number: S-180/2020). Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors have no relevant financial or non-financial interests to disclose.